Colonization by Clostridium difficile in hospitalized children: risk factors and typification of the isolated strains

M Camorlinga1, O Muñoz, H Guiscafré

  • 1Unidad de Investigación Clínica en Enfermedades Infecciosas y Parasitarias, Instituto Mexicano del Seguro Social, D.F.

Archivos De Investigacion Medica
|January 1, 1991
PubMed

Insights

Clostridium difficile colonization was studied in hospitalized children. Antibiotic use impacted colonization rates in infants, and pre-hospitalization strains were more toxigenic.

Area of Science:

  • Microbiology
  • Pediatric Infectious Diseases
  • Epidemiology

Background:

  • Clostridium difficile is a significant cause of hospital-acquired infections.
  • Understanding colonization patterns in pediatric populations is crucial for infection control.

Purpose of the Study:

  • To determine the frequency of Clostridium difficile colonization in hospitalized children under 15.
  • To investigate risk factors such as antibiotic use and nutritional status.
  • To characterize isolated Clostridium difficile strains based on toxigenicity and resistance.

Main Methods:

  • Fecal samples were collected from 273 hospitalized children over 11 months.
  • Colonization rates were analyzed by age group (neonates, <1 year, 1-5 years, 5-15 years).
  • Risk factors (antibiotics, nutrition) and strain characteristics (toxigenicity, antibiotic sensitivity, phage/bacteriocin typing) were assessed.

Main Results:

  • Colonization rates varied by age: 9.7% in <1 year, 8.3% in 1-5 years, 4.2% in 5-15 years.
  • Antibiotic treatment significantly decreased colonization in children under one year.
  • Pre-hospitalization strains were more toxigenic; specific resistotypes and phagobacteriocin types were associated with hospital-acquired strains.

Conclusions:

  • Clostridium difficile colonization is present in hospitalized children, with higher rates in younger age groups.
  • Antibiotic stewardship may be particularly important for preventing colonization in infants.
  • Strain characterization reveals differences between community-acquired and hospital-acquired Clostridium difficile infections.

Related Concept Videos

Development of Human Microbiota01:30

Development of Human Microbiota

The human microbiota begins developing at birth and undergoes continual change as we age. Infancy marks a critical period of microbial sensitivity, offering a “window of opportunity” during which beneficial microbes help mature the immune system. By age three, children typically develop a more stable and diverse microbial community. Newborns acquire microbes from their immediate environment; vaginal delivery favors maternal vaginal microbes, while cesarean births favor microbes from the skin...
Dysbiosis of the Gut Microbiota01:18

Dysbiosis of the Gut Microbiota

The human gut microbiome includes a diverse array of microbial species, including beneficial commensals and opportunistic pathogens, which interact to support host health. These microbes contribute to essential functions such as nutrient metabolism, immune system modulation, and maintenance of intestinal barrier integrity. However, disruptions to this equilibrium—referred to as dysbiosis—can have widespread physiological consequences.Dysbiosis is often characterized by reduced microbial...
Colonisation of Pathogens01:25

Colonisation of Pathogens

Pathogen colonization of host tissues is a critical step in the development of infectious diseases. Various pathogenic microorganisms, including bacteria, fungi, viruses, and protozoa, have evolved complex strategies to attach to, invade, and persist within host environments. These mechanisms enable pathogens to establish infections, evade immune responses, and resist antimicrobial treatments.Attachment to Host CellsIn bacteria, colonization typically begins with adherence to host epithelial...
Bacterial Gastroenteritis01:18

Bacterial Gastroenteritis

Bacterial gastroenteritis, characterized by diarrhea, abdominal cramps, and vomiting, is often caused by ingestion of contaminated food or water and is frequently associated with pathogenic Escherichia coli strains. These microbes exploit two principal mechanisms to inflict disease.Shiga toxin–producing E. coli, also referred to as STEC—notably O157:H7—release Shiga toxins that target ribosomes, blocking protein synthesis. The B subunit of the toxin binds the host glycolipid receptor...
Cholera01:25

Cholera

Cholera is an acute gastrointestinal disease caused by the Gram-negative bacterium Vibrio cholerae. It is transmitted primarily via the fecal-oral route through the ingestion of contaminated water or food.Vibrio cholerae is a motile, Gram-negative bacterium of the family Vibrionaceae, primarily associated with waterborne outbreaks in areas with inadequate sanitation. Although over 200 serogroups of V. cholerae exist, only O1 and O139 are responsible for epidemic cholera. The O1 serogroup,...
Clinical Significance of Antibiotic Resistance01:25

Clinical Significance of Antibiotic Resistance

Methicillin-resistant Staphylococcus aureus (MRSA) presents a critical public health threat, arising from its capacity to resist β-lactam antibiotics due to acquisition of the mecA gene within the staphylococcal cassette chromosome mec (SCCmec). This gene encodes penicillin-binding protein 2a (PBP2a), which impairs binding efficacy of methicillin and other β-lactams. MRSA has evolved into distinct clonal lineages impacting humans and animals alike, reinforcing its significance within the One...